Page last updated: 2024-10-30

medazepam and Psychophysiologic Disorders

medazepam has been researched along with Psychophysiologic Disorders in 2 studies

Medazepam: A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.

Psychophysiologic Disorders: A group of disorders characterized by physical symptoms that are affected by emotional factors and involve a single organ system, usually under AUTONOMIC NERVOUS SYSTEM control. (American Psychiatric Glossary, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hertrich, O1
Sim, M1
Bindman, E1
Morrison, I1
Sandilands, D1

Trials

1 trial available for medazepam and Psychophysiologic Disorders

ArticleYear
A double-blind controlled therapeutic trial of lorazepam vs medazepam in psychosomatic conditions in general practice.
    The British journal of clinical practice, 1975, Volume: 29, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Family Pr

1975

Other Studies

1 other study available for medazepam and Psychophysiologic Disorders

ArticleYear
[Ataractic treatment in psychiatry and general medicine. Review of preparations. 9].
    Fortschritte der Medizin, 1983, Oct-27, Volume: 101, Issue:40

    Topics: Adjustment Disorders; Anthracenes; Anti-Anxiety Agents; Benzodiazepines; Humans; Lorazepam; Maprotil

1983